300158 振東製藥
按盤價 
6.010 -0.120 (-1.958%)
6.010 -0.120 (-1.958%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.553 | -29.934 | -0.843 | -0.769 | 38.143 |
| 總資產報酬率 ROA (%) | 0.429 | -23.803 | -0.691 | -0.616 | 29.581 |
| 投入資產回報率 ROIC (%) | 0.536 | -28.856 | -0.807 | -0.728 | 34.670 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.925 | 47.490 | 50.375 | 49.314 | 59.667 |
| 營業利潤率 (%) | 2.439 | -24.055 | -0.827 | -0.159 | 61.282 |
| 息稅前利潤/營業總收入 (%) | 2.096 | -44.301 | -1.303 | 0.126 | 61.457 |
| 淨利潤/營業總收入 (%) | 0.830 | -44.863 | -1.320 | -1.529 | 51.232 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 17.117 | 31.235 | 401.713 | 3,667.027 | 2.700 |
| 價值變動淨收益/利潤總額(%) | 21.950 | 7.412 | -119.491 | -1,250.833 | 94.803 |
| 營業外收支淨額/利潤總額(%) | -18.079 | 45.651 | 20.453 | -12.118 | -0.175 | 償債能力分析 |
| 流動比率 (X) | 3.138 | 2.562 | 4.864 | 4.038 | 4.680 |
| 速動比率 (X) | 2.354 | 1.944 | 3.560 | 3.150 | 4.159 |
| 資產負債率 (%) | 19.565 | 26.541 | 16.769 | 20.266 | 20.201 |
| 帶息債務/全部投入資本 (%) | 1.301 | 2.084 | 1.211 | 2.893 | 4.074 |
| 股東權益/帶息債務 (%) | 7,504.786 | 4,613.866 | 7,972.653 | 3,282.543 | 2,314.544 |
| 股東權益/負債合計 (%) | 415.569 | 279.601 | 499.702 | 395.756 | 396.256 |
| 利息保障倍數 (X) | 68.329 | 1,087.764 | 4.940 | 0.471 | 218.054 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 85.021 | 69.336 | 66.030 | 76.499 | 71.145 |
| 存貨周轉天數 (天) | 186.013 | 227.454 | 227.064 | 191.597 | 154.396 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 16/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
